FN2 Earnings Intelligence

DexCom, Inc. analyst ratings

DexCom, Inc. (DXCM) analyst consensus, price targets, and firm-level rating history from FN2 Research.

Analyst Consensus ?

ConsensusBuy52 ratings
Bullish4280.8%
Neutral815.4%
Bearish23.8%

Analyst 52W Price Targets

$78.9Current
$28.12Low
$80.81Average
$146High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
BTIG Buy BuyMaintainOct 12, 2026
RBC Capital Outperform OutperformMaintainOct 1, 2026
Truist Securities Buy BuyMaintainSep 18, 2026
TD Cowen Buy BuyMaintainSep 18, 2026
Argus Research Buy BuyMaintainAug 4, 2026
Show 47 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $78.9. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Mizuho SecuritiesAnthony Petrone$100$85.92 +26.7%Oct 13, 2026
BarclaysAnalyst unavailable$115$83.39 +45.8%Oct 6, 2026
RBC CapitalAnalyst unavailable$105$86.29 +33.1%Oct 1, 2026
Truist FinancialAnalyst unavailable$102$87.93 +29.3%Sep 18, 2026
Argus ResearchSteve Silver$96$87 +21.7%Aug 4, 2026
See 84 more

Track every rating change on DXCM the moment it posts. Free to start.

Start free

Get the DXCM recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.